HYPD vs. CYBN, TIL, PBYI, VYGR, TLSA, IMAB, LFVN, ENTA, IPHA, and ACOG
Should you be buying Hyperion DeFi stock or one of its competitors? The main competitors of Hyperion DeFi include Cybin (CYBN), Instil Bio (TIL), Puma Biotechnology (PBYI), Voyager Therapeutics (VYGR), Tiziana Life Sciences (TLSA), I-Mab (IMAB), Lifevantage (LFVN), Enanta Pharmaceuticals (ENTA), Innate Pharma (IPHA), and Alpha Cognition (ACOG). These companies are all part of the "pharmaceutical products" industry.
Hyperion DeFi vs. Its Competitors
Hyperion DeFi (NASDAQ:HYPD) and Cybin (NYSE:CYBN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.
25.8% of Hyperion DeFi shares are owned by institutional investors. Comparatively, 17.9% of Cybin shares are owned by institutional investors. 7.1% of Hyperion DeFi shares are owned by insiders. Comparatively, 15.0% of Cybin shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Cybin has a net margin of 0.00% compared to Hyperion DeFi's net margin of -62,238.41%. Hyperion DeFi's return on equity of 0.00% beat Cybin's return on equity.
Hyperion DeFi has higher revenue and earnings than Cybin. Cybin is trading at a lower price-to-earnings ratio than Hyperion DeFi, indicating that it is currently the more affordable of the two stocks.
Hyperion DeFi has a beta of 2.47, indicating that its share price is 147% more volatile than the S&P 500. Comparatively, Cybin has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500.
In the previous week, Hyperion DeFi and Hyperion DeFi both had 1 articles in the media. Hyperion DeFi's average media sentiment score of 0.00 beat Cybin's score of -0.18 indicating that Hyperion DeFi is being referred to more favorably in the media.
Hyperion DeFi presently has a consensus price target of $2.00, indicating a potential downside of 84.48%. Cybin has a consensus price target of $85.00, indicating a potential upside of 1,039.41%. Given Cybin's stronger consensus rating and higher possible upside, analysts clearly believe Cybin is more favorable than Hyperion DeFi.
Summary
Cybin beats Hyperion DeFi on 8 of the 15 factors compared between the two stocks.
Get Hyperion DeFi News Delivered to You Automatically
Sign up to receive the latest news and ratings for HYPD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hyperion DeFi Competitors List
Related Companies and Tools
This page (NASDAQ:HYPD) was last updated on 7/16/2025 by MarketBeat.com Staff
Free HYPD Stock Alerts